Search Details

Word: beecham (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

...medical community was so excited about the prospect of a vaccine against Lyme disease that the Yale and Harvard researchers won backing from the Smith-Kline and Beecham pharmaceuticals company...

Author: By Andrew L. Wright, SPECIAL TO THE CRIMSON | Title: Lyme Vaccine Remains Untested | 7/30/1993 | See Source »

...works admirably demonic (e.g. Don - Giovanni), most smiled on his sonatas as works of tinkly charm appropriate for young ladies to perform in the parlor. That view of Mozart as a divinely inspired but childlike innocent endured well into this century. Only a few enthusiasts such as Sir Thomas Beecham and Artur Schnabel kept emphasizing the depth and drama in his later symphonies and piano works ("Too easy for students and too difficult for artists," said Schnabel). Serious scholarship helped; so did the revival of period instruments. The 1948 arrival of the LP record vastly broadened the availability...

Author: /time Magazine | Title: Hats Off to A Genius! | 2/11/1991 | See Source »

...Germany's Bayer AG, American firms average 40% of their sales outside the country. This year's three biggest drug-company mergers all involved U.S. companies. Bristol-Myers (1988 sales: $6 billion) joined Squibb of Princeton, N.J. ($2.6 billion); Philadelphia's SmithKline Beckman ($3 billion) merged with Britain's Beecham ($3 billion); Merrell Dow ($1.3 billion) of Midland, Mich., merged with Marion Labs ($752 million) of Kansas City. "Pharmaceuticals is the one industry in which the U.S. firms are the biggest and growing the fastest," says Jay Silverman, a health-care analyst at the Nomura Research Institute in New York...

Author: /time Magazine | Title: The Price Isn't Right | 1/8/1990 | See Source »

SmithKline Beecham...

Author: NO WRITER ATTRIBUTED | Title: COMPANIES BY INDUSTRY | 10/20/1989 | See Source »

...another deal that was driven by global ambitions, shareholders of SmithKline Beckman, developer of the anti-ulcer drug Tagamet, last week approved a merger with London's Beecham Group, which has built strong European markets. One week earlier Dow Chemical agreed to merge its Merrell Dow Pharmaceuticals subsidiary with Marion Laboratories, whose chief prescription drug is Cardizem, an angina treatment. In the afterglow of the Time-Warner marriage and other such deals, companies in many industries may gain greater confidence to embark on friendly combinations...

Author: /time Magazine | Title: Friendly Medicine | 8/7/1989 | See Source »

Previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | Next